| Identification | Back Directory | [Name]
N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]cyclohexyl}benzenesulfonamide | [CAS]
891016-02-7 | [Synonyms]
ML-SI3
CCG-143140
N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]cyclohexyl}benzenesulfonamide
Benzenesulfonamide, N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]cyclohexyl]- | [EINECS(EC#)]
816-721-6 | [Molecular Formula]
C23H31N3O3S | [MDL Number]
MFCD14811190 | [MOL File]
891016-02-7.mol | [Molecular Weight]
429.58 |
| Chemical Properties | Back Directory | [Boiling point ]
589.3±60.0 °C(Predicted) | [density ]
1.26±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO : 50 mg/mL (116.39 mM; Need ultrasonic) | [form ]
Solid | [pka]
11.63±0.40(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Biological Activity]
ML-SI3 is a 4-diastereomer racemate (2 cis and 2 trans isomers) with a cation channel TRPML1-blocking (IC50 = 3.1 μM/trans18.5 μM/cis against 5 μM ML-SA1-induced cellular calcium response) and TRPML2-activating activity (EC50 = 3.3 μM/trans9.4 μM/cis)while exhibiting much weaker TRPML3 potency (EC50 = 28.5 μM/transIC50 = 29.0 μM/cis). ML-SI3 is shown to compete against ML-SA1 for binding the same TRPML1 hydrophobic cavity. Comparing with ML-SI1 (GW405833)ML-SI3 is more potent and not agonist-dependenteffectively antagonizing against TRPML1 activation by both MK6-83 and ML-SA1. |
|
|